Table 4.
Association between nocturia (≥2 times) and mortality according to comorbidities
| Variable | All-cause mortality |
Cardiovascular disease mortality |
||
|---|---|---|---|---|
| HR (95% CI) | P-value | HR (95% CI) | P-value | |
| Without DM at baseline survey | 1.21 (1.03–1.41) | 0.017 | 1.44 (1.03–2.02) | 0.033 |
| With DM at baseline survey | 1.26 (1.05–1.51) | 0.013 | 1.61 (1.06–2.45) | 0.026 |
| Without HTN at baseline survey | 1.41 (1.04–1.91) | 0.028 | 2.24 (1.05–4.80) | 0.038 |
| With HTN at baseline survey | 1.21 (1.06–1.37) | 0.004 | 1.45 (1.09–1.91) | 0.009 |
| Without DLP at baseline survey | 1.15 (0.93–1.43) | 0.210 | 1.10 (0.66–1.82) | 0.716 |
| With DLP at baseline survey | 1.26 (1.10–1.45) | 0.001 | 1.68 (1.23–2.28) | 0.001 |
| Without CVD at baseline survey | 1.27 (1.09–1.47) | 0.002 | 1.37 (0.95–1.97) | 0.090 |
| With CVD at baseline survey | 1.16 (0.96–1.41) | 0.116 | 1.72 (1.17–2.53) | 0.006 |
Multiple Cox regression model adjusted for age, race, body mass index, smoking status, alcohol consumption, sleep duration, dyslipidemia, hypertension, and diabetes mellitus.
HR, hazard ratio; CI, confidence interval; DM, diabetes mellitus; HTN, hypertension; DLP, dyslipidemia; CVD, cardiovascular disease.